• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Dimethoxybenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Methoxybenzenes Dimethoxybenzenes

Research Brief on 1-(Bromomethyl)-2,4-dimethoxybenzene (CAS: 161919-74-0) in Chemical Biology and Pharmaceutical Applications

1-(Bromomethyl)-2,4-dimethoxybenzene (CAS: 161919-74-0) is a key intermediate in organic synthesis, particularly in the development of pharmaceuticals and bioactive molecules. Recent studies have highlighted its utility in the construction of complex molecular architectures, including heterocyclic compounds and functionalized aromatics. This research brief synthesizes the latest findings on its applications, synthetic methodologies, and potential therapeutic implications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's role in the synthesis of novel kinase inhibitors. Researchers utilized 1-(Bromomethyl)-2,4-dimethoxybenzene as a versatile alkylating agent to introduce the dimethoxybenzyl moiety into lead compounds, enhancing their binding affinity to target proteins. The study reported a 40% improvement in inhibitory activity against specific cancer-related kinases compared to previous analogs.

In the field of antimicrobial development, a recent Bioorganic & Medicinal Chemistry Letters publication (2024) described the use of this compound in creating quaternary ammonium derivatives with potent activity against drug-resistant Gram-positive bacteria. The bromomethyl group's reactivity enabled efficient functionalization, yielding compounds with MIC values as low as 0.5 μg/mL against MRSA strains.

Advanced synthetic applications have emerged from materials science research. A 2024 ACS Applied Materials & Interfaces paper detailed its incorporation into photo-responsive polymers. The dimethoxybenzene moiety provided excellent light absorption properties, while the bromomethyl group served as a cross-linking site, creating materials with tunable mechanical properties for drug delivery applications.

Mechanistic studies have provided new insights into the compound's reactivity. Quantum chemical calculations published in Organic & Biomolecular Chemistry (2023) revealed that the bromomethyl group's electrophilicity is significantly influenced by the electron-donating methoxy substituents, explaining its selective reactivity patterns observed in various synthetic applications.

From a safety perspective, recent toxicological assessments (2024) indicate that proper handling protocols are essential due to the compound's alkylating potential. However, its rapid degradation in aqueous environments suggests minimal environmental persistence, making it a relatively sustainable choice for industrial applications.

Future research directions highlighted in these studies include exploring its use in PROTAC (proteolysis targeting chimera) development and as a building block for covalent inhibitors in targeted cancer therapies. The compound's unique combination of reactivity and stability positions it as a valuable tool in modern drug discovery pipelines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)